Barriers to immunosuppressive medication adherence in high-risk adult renal transplant recipients

Dialysis and Transplantation

Volumn 40, Issue 2, 2011, Pages 60-66

  Constantiner, Melissa ^a   Cukor, Daniel ^b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b YESHIVA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; GRAFT RECIPIENT; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSANT THERAPY ADHERENCE SCALE; IMMUNOSUPPRESSANT THERAPY BARRIER SCALE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LONG TERM MEDICATION BEHAVIOR SELF EFFICACY SCALE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; RISK FACTOR; SELF CONCEPT; SELF REPORT; UNITED STATES; UNIVERSITY HOSPITAL;

EID: 79951805974     PISSN: 00902934     EISSN: 19326920     Source Type: Journal    
DOI: 10.1002/dat.20536     Document Type: Article

References (50)

1. Dew MA, DiMartini AF, De Vito Dabbs A, et al. Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation. 2007;83:858-873. (Pubitemid 46682726)
2. Denhaerynck K, Dobbels F, Cleemput I, et al. Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review. Transplant Int. 2005;18:1121-1133. (Pubitemid 41726755)
3. Chisholm MA, Kwong WJ, Spivey CA. Associations of characteristics of renal transplant recipients with clinicians' perceptions of adherence to immunosuppressant therapy. Transplantation. 2007;84:1145-1150. (Pubitemid 350125357)
4. Vlaminck H, Maes B, Evers G, et al. Prospective study on late consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant patients. Am J Transplant. 2004;4:1509-1513. (Pubitemid 39159066)
5. Russell CL, Conn VS, Ashbaugh C, et al. Intrasubject medication adherence patterns. Clin Nurs Res. 2007;16:153-163.
6. Baines LS, Joseph JT, Jindal RM. Compliance and late acute rejection after kidney transplantation: a psycho-medical perspective. Clin Transplant. 2002;16:69-73. (Pubitemid 34555492)
7. Butler JA, Peveler RC, Roderick P, et al. Measuring compliance with drug regimens after renal transplantation: comparison of self-report and clinician rating with electronic monitoring. Transplantation. 2004;77:786-789. (Pubitemid 38366993)
8. Yen EF, Hardinger K, Brennan DC, et al. Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant. Am J Transplant. 2004;4:1703-1708. (Pubitemid 39312307)
9. Cleemput I, Kesteloot K, Vanrenterghem Y, et al. The economic implications of non-adherence after renal transplantation. Pharmacoeconomics. 2004;22:1217-1234. (Pubitemid 40075723)
10. Jindal RM, Joseph JT, Morris MC, et al. Noncompliance after kidney transplantation: a systematic review. Transplant Proc. 2003;35:2868-2872. (Pubitemid 38102076)
11. Laupacis A, Keown P, Pus N, et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int. 1996;50:235-242. (Pubitemid 26323718)
12. Liem YS, Bosch JL, Hunink MG. Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis. ValueHealth. 2008;11:733-741. (Pubitemid 352032818)
13. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341:1725-1730.
14. Hansen R, Seifeldin R, Noe L. Medication adherence in chronic disease: issues in posttransplant immunosuppression. Transplant Proc. 2007;39:1287-1300. (Pubitemid 46915526)
15. Sabate E. Adherence to Long-term Therapies: Evidence for Action. Geneva, Switzerland: World Health Organization; 2003.
16. Cukor D, Rosenthal DS, Jindal RM, et al. Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipients. Kidney Int. 2009;75:1223-1229.
17. Beck AT, Steer RA, Carbin MG. Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clin Psychol Rev. 1988;8:77-100. (Pubitemid 18045797)
18. Kimmel PL, Peterson RA, Weihs KL, et al. Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis outpatients. Kidney Int. 2000;57:2093-2098. (Pubitemid 30252302)
19. Cukor D, Coplan J, Brown C, et al. Depression and anxiety in urban hemodialysis patients. Clin J Am Soc Nephrol. 2007;2:484-490.
20. Finkelstein FO, Finkelstein SH. Depression in chronic dialysis patients: assessment and treatment. Nephrol Dials Transplant. 2000;15:1911-1913.
21. Hedayati SS, Bosworth HB, Briley LP, et al. Death or hospitalization of patients on chronic hemodialysis is associated with a physician-based diagnosis of depression. Kidney Int. 2008;74:930-936.
22. Cukor D, Peterson RA, Cohen SD, et al. Depression in end-stage renal disease hemodialysis patients. Nat Clin Pract Nephrol. 2006;2:678-687. (Pubitemid 44862705)
23. Watnick S, Kirwin P, Mahnensmith R, et al. The prevalence and treatment of depression among patients starting dialysis. Am J Kidney Dis. 2003;41:105-110. (Pubitemid 36043357)
24. Chisholm MA, Lance CE, Williamson GM, et al. Development and validation of the immunosuppressant therapy adherence instrument (ITAS). Patient Educ Counsel. 2005;59:13-20. (Pubitemid 41399874)
25. Chisholm MA, Lance CE, Mulloy LL. Patient factors associated with adherence to immunosuppressant therapy in renal transplant recipients. Am J Health-Syst Pharm. 2005;62:1775-1781. (Pubitemid 41243391)
26. Wilks SE, Spivey CA, Chisholm-Burns MA. Psychometric re-evaluation of the immunosuppressant therapy adherence scale among solid-organ transplant recipients. J Eval Clin Pract. 2010;16:64-68.
27. Chisholm MA, Lance CE, Williamson GM, et al. Development and validation of an immunosuppressant therapy adherence barrier instrument. Nephrol Dial Transplantation. 2005;20:181-188. (Pubitemid 40214334)
28. De Geest S, Borgermans L, Gemoets H, et al. Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation. 1995;59:340-347.
29. Geest S, Abraham I, Gemoets H, et al. Development of the long-term medication behaviour self-efficacy scale: qualitative study for item development. J Adv Nurs. 1994;19:233-238.
30. Denhaerynck K, Abraham I, Gourley G, et al. Validity testing of the Long-Term Medication Behavior Self-Efficacy Scale. J Nurs Measure. 2003;11:267-282. (Pubitemid 40208086)
31. Joseph JT, Baines LS, Morris MC, et al. Quality of life after kidney and pancreas transplantation: a review. Am J Kidney Dis. 2003;42:431-445. (Pubitemid 37048119)
32. Schafer-Keller P, Steiger J, Bock A, et al. Diagnostic accuracy of measurement methods to assess non-adherence to immunosuppressive drugs in kidney transplant recipients. Am J Transplant. 2008;8:616-626. (Pubitemid 351287554)
33. Siegal BR, Greenstein SM. Postrenal transplant compliance from the perspective of African-Americans, Hispanic-Americans, and Anglo-Americans. Adv Renal Replace Ther. 1997;4:46-54. (Pubitemid 27030456)
34. Butkus DE, Meydrech EF, Raju SS. Racial differences in the survival of cadaveric renal allografts. Overriding effects of HLA matching and socioeconomic factors. N Engl J Med. 1992;327:840-845.
35. Schweizer RT, Rovelli M, Palmeri D, et al. Noncompliance in organ transplant recipients. Transplantation. 1990;49:374-377. (Pubitemid 20088179)
36. Kiley DJ, Lam CS, Pollak R. A study of treatment compliance following kidney transplantation. Transplantation. 1993;55:51-56. (Pubitemid 23033944)
37. Greenstein S, Siegal B. Compliance and noncompliance in patients with functional renal transplant: a multicenter study. Transplantation. 1998; 66:1718-1726. (Pubitemid 29034998)
38. Denhaerynck K, Steiger J, Bock A, et al. Prevalence and risk factors of non-adherence with immunosuppressive medication in kidney transplant patients. Am J Transplant. 2007;7:108-116. (Pubitemid 44952862)
39. Ghods AJ, Nasrollahzadeh D, Argani H. Risk factors for noncompliance to immunosuppressive medications in renal transplant recipients. Transplant Proc. 2003;35:2609-2611. (Pubitemid 37378084)
40. Butler JA, Peveler RC, Roderick P, et al. Modifiable risk factors for non-adherence to immunosuppressants in renal transplant recipients: a cross-sectional study. Nephrol Dial Transplant. 2004;19:3144-3149. (Pubitemid 40057641)
41. Gremigni P, Bacchi F, Turrini C, et al. Psychological factors associated with medication adherence following renal transplantation. Clin Transplant. 2007;21:710-715. (Pubitemid 350056137)
42. Raiz LR, Kilty KM, Henry ML, et al. Medication compliance following renal transplantation. Transplantation. 1999;68:51-55. (Pubitemid 29352829)
43. Papajcik D, Mastroianni B, Goormastic M, et al. A tool to identify risk factors for noncompliance in the adult renal transplant recipient. Transplant Proc. 1999;31:84S-86S.
44. Frazier PA, Davis-Ali SH, Dahl KE. Correlates of noncompliance among renal transplant recipients. Clin Transplant. 1994;8:550-557. (Pubitemid 24361561)
45. Teixeira de Barros C, Cabrita J. Noncompliance with immunosuppressive therapy: prevalence and determinants. Transplant Proc. 2000;32:2633-2633.
46. Sketris I, Waite N, Grobler K, et al. Factors affecting compliance with cyclosporine in adult renal transplant patients. Transplant Proc. 1994;26:2538-2541. (Pubitemid 24329220)
47. Schmid-Mohler G, Thut MP, Thrich RP, et al. Non-adherence to immunosuppressive medication in renal transplant recipients within the scope of the integrative model of behavioral prediction: a cross-sectional study. Clin Transplant. 2009;24:213-222.
48. Russell CL, Kilburn E, Conn VS, et al. Medication-taking beliefs of adult renal transplant recipients. Clin Nurs Specialist. 2003;17:200-208.
49. Vasquez EM, Tanzi M, Benedetti E, et al. Medication noncompliance after kidney transplantation. Am J Health-Syst Pharm. 2003;60:266-269. (Pubitemid 36749051)
50. Weng FL, Israni AK, Joffe MM, et al. Race and electronically measured adherence to immunosuppressive medications after deceased donor renal transplantation. J Am Soc Nephrol. 2005;16:1839-1848. (Pubitemid 41716492)